HOME >> MEDICINE >> NEWS
Cedars-Sinai Medical News Tips

Welcome to the inaugural edition of Cedars-Sinai Medical Center's "Top Tips." This semi-monthly service is designed especially for health and medical reporters and is offered free of charge by the Cedars-Sinai Medical Center Public Relations Department. To receive "Top Tips" twice each month via e-mail, please send your name, organization, phone and fax numbers, plus e-mail address, to sandy@vancommunications.com. If you are already receiving this service and do not wish to, you may cancel by sending to the same e-mail address with the word "unsubscribe" entered in the subject field. To pursue any of these story ideas, call 1-800-396-1002. Thank you.

DIABETES DRUG AND ACCUTANE BLOCK BREAST CANCER CELL GROWTH
Breast cancer cells exposed to a diabetes drug (Troglitazone) and the Vitamin A compound Accutane stopped multiplying and died on cue in laboratory and animal studies conducted at Cedars-Sinai Medical Center. The drug combination appears to have no adverse effect on healthy cells, either in laboratory studies or in immunodeficient mice injected with human breast cells that form tumors.
Interview: H. Phillip Koeffler, M.D., Director of Hematology/Oncology, Cedars-Sinai

NEW BRAIN TUMOR SUPPORT GROUP OFFERS PATIENTS AND FAMILIES MONTHLY UPDATES ON NEW TREATMENT OPTIONS PLUS PSYCHOLOGICAL SUPPORT
A new Brain Tumor Support Group at Cedars-Sinai Medical Center's Neurosurgical Institute provides patients and their families with psychological support as well as monthly updates on the latest in treatment options, including radiation, chemotherapy and future strategies using gene therapy and immunology. The series of programs combines medical updates with psychological support groups.
Interview: World-renowned brain surgeon Keith L. Black, M.D., and brain tumor patients

CLINICAL TRIALS AT CEDARS-SINAI OFFER NEW OPTION FOR ANGINA PAIN SUFFERERS
Cardiac patients who are t
'"/>

Contact: Sandra Van or Roberta Nichols
sandy@vancommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
27-Aug-1998


Page: 1 2

Related medicine news :

1. Cedars-Sinai medical tipsheet for Dec. 2004
2. Cedars-Sinai October 2004 medical tipsheet
3. Cedars-Sinai Medical tipsheet for May 2004
4. Cedars-Sinai receives full AAHRPP accreditation for all research involving human subjects
5. Cedars-Sinai March medical tipsheet
6. Cedars-Sinai researchers identify a gene that causes insulin resistance in Mexican Americans
7. Medical geneticist at Cedars-Sinai awarded $8.5 million NIH research grant
8. Cedars-Sinai researchers detail events that enable brain tumors to weaken immune system
9. Cedars-Sinai Medical tipsheet for July 2003
10. Cedars-Sinai researchers to present findings at Amerian College of Cardiology Scientific Meeting
11. Patients who need cardiac resynchronization therapy may be eligible for Cedars-Sinai clinical trials

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cedars Sinai Medical News Tips

(Date:7/30/2015)... ... 2015 , ... In an effort to provide the twenty four hour continuous ... in his practice. , The decision will also allow him to spend more time ... transferring his in-patient admissions to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal has ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... TikiLIVE, has worked to protect victims in San Diego, California’s Gaslamp Quarter Plaza ... used by Gaslamp Quarter Plaza actively monitor the area for any suspicious activity. ...
(Date:7/30/2015)... ... July 30, 2015 , ... " DevExpress ... takes a look at small, medium, and large businesses making an impact in ... the business review and shared with viewers how DevExpress has provided software development ...
(Date:7/30/2015)... ... July 30, 2015 , ... The ... Institute Scholar Program. In partnership with Patient Experience Institute, these offerings reinforce the ... on the front lines and throughout the experience movement, and provide information and ...
(Date:7/30/2015)... Beach, California (PRWEB) , ... July 30, 2015 ... ... and services, announced today that the latest issue of Inclusive™ magazine, its multimedia ... digital platforms. The digital edition of the new issue, Volume 6, Issue 2, ...
Breaking Medicine News(10 mins):Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4
(Date:7/30/2015)... , July 30, 2015  Medimetriks Pharmaceuticals, ... the second Phase III clinical study for Ozenoxacin, ... impetigo.  Medimetriks owns the exclusive U.S. rights to ... trial, conducted at 44 centers with an emphasis ... patients aged 2 months and older with a ...
(Date:7/30/2015)... 30, 2015 Vermillion, Inc. (VRML), ... disease, announced today it will report its ... market close on Thursday, August 13, 2015, ... webcast at 4:30pm Eastern.Conference Call and Webcast:  ... Eastern/1:30pm Pacific  Domestic: , 888-430-8691International: ...
(Date:7/30/2015)... -- Big Cloud Analytics, Inc. (BCA), a leading provider ... working with Intel Corporation to showcase Internet of ... Healthcare Technology Alliance. The recently formed alliance is ... technology companies and academic institutions. Its purpose is ... in rapidly evolving and growing areas of health ...
Breaking Medicine Technology:Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3
Cached News: